Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Rare Disease topic
No spam. Unsubscribe anytime.
California Senate adopts resolution designating June 10, 2025, as FSGS Awareness Day
Summary
Sen. Weber Pearson presented Senate Concurrent Resolution 87 to recognize June 10, 2025, as Focal Segmental Glomerulosclerosis (FSGS) Awareness Day; the Senate adopted the measure by voice/roll call, recorded as 34-0.
The California State Senate on the floor adopted Senate Concurrent Resolution 87 to designate June 10, 2025, as Focal Segmental Glomerulosclerosis (FSGS) Awareness Day. The measure was adopted by a roll-call tally of 34 ayes, 0 noes.
Sen. Weber Pearson presented the resolution, saying, “Today, I rise to present SCR 87, which will recognize 06/10/2025 as focal segmental glomerulosclerosis or FSGS awareness day.” She described FSGS as a rare, progressive kidney disease that “causes scarring in the kidney and often leads to kidney failure,” and asked members for an I vote.
The resolution spotlights the disease’s impact and calls for education, earlier diagnosis, research and investment. Pearson told the Senate that FSGS “affects all regardless of race, gender, race, or even lifestyle,” and cited several statistics: that the disease is a leading cause of end-stage kidney disease in children; that about half of patients will require dialysis or a kidney transplant within five to 10 years of diagnosis; that recurrence after transplant can affect up to 50% of patients; and that African Americans experience FSGS at rates four to five times higher than white Americans. The senator also noted an average delay in diagnosis of five to seven years and a shortage of nephrologists for rare kidney disorders.
The Secretary conducted a roll call after the presentation. The clerk recorded 34 ayes and 0 noes; the presiding officer announced, “The ayes are 34. The noes are 0. The measure is adopted.” Following adoption, Pearson and the presiding officer recognized guests in the gallery who the resolution’s proponents said had lived experience with FSGS, including Kendra Carruth, a coordinator with NephCure (a nonprofit focused on rare kidney disease); Matt Coronel, identified as an FSGS patient; Cindy Michelle Atman, introduced as a guest; and Shonda Robinson, identified as a kidney donor.
No formal debate or amendments to SCR 87 were recorded on the floor in the provided transcript. The resolution, as presented, is a nonbinding recognition intended to raise awareness of FSGS, encourage earlier diagnosis and support for patients and caregivers.
The resolution’s adoption was celebrated by proponents and the guests recognized on the Senate floor; the Senate then continued with ceremonial introductions and other routine business.
